Patents Represented by Attorney, Agent or Law Firm Burns, Doane, Doane, Swecker & Mathis LLP
  • Biological reagents and methods for determining the mechanism in the generation of &bgr;-amyloid peptide
    Patent number: 6486350
    Abstract: Disclosed are biological reagents which comprise compounds that inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in determining the cellular mechanism involved in the generation of &bgr;-amyloid peptide.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: November 26, 2002
    Assignees: Elan Pharmaceuticals Inc., Eli Lilly & Company
    Inventors: James E. Audia, Paul A. Hyslop, Jeffrey S. Nissen, Richard C. Thompson, Jay S. Tung, Laura I. Tanner